Mizuho initiates Castle Biosciences coverage with Outperform rating, $60 target
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Shanghai Composite Opens 1.3% Lower
M impact | EQUITY | Oct 30, 2026, 01:32 AM UTC
Calmer Co International Posts Q1 FY27 Revenue of A$2.44 Million
M impact | EQUITY | Oct 30, 2026, 01:27 AM UTC
China’s CSI Index Set to Open Down 1.4%
M impact | EQUITY | Oct 30, 2026, 01:27 AM UTC
ChiNext Price Index Opens 3.3% Lower at 2434.80
M impact | EQUITY | Oct 30, 2026, 01:27 AM UTC
China's STAR 50 Index Opens 3% Lower, Hits 14-Month Low
M impact | EQUITY | Oct 30, 2026, 01:26 AM UTC
Nikkei Stock Average Falls 2.8% to 62,828.28
M impact | EQUITY | Oct 30, 2026, 01:26 AM UTC